Split 3rd Circ. Rejects Janssen, Bristol Myers Pricing Appeal

A split Third Circuit panel Thursday shot down another challenge to the Medicare drug pricing negotiation, this time rejecting a consolidated appeal from Bristol Myers Squibb and Janssen and upholding a...

Already a subscriber? Click here to view full article